Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Post by mindseye1on Apr 24, 2008 9:27am
293 Views
Post# 15004419

Pfizer acquires animal health products..fyi

Pfizer acquires animal health products..fyi
( BW)(PFIZER-7)(PFE) Pfizer Animal Health Enters into Agreement to
Acquire Animal Health Products from Schering-Plough

Business Editors

PARIS--(BUSINESS WIRE)--April 23, 2008--Pfizer Animal Health today
announced that it has entered into an agreement to acquire multiple
product franchises from Schering-Plough Corporation covering all major
animal health species including cattle, swine, equine, and companion
animal.

Specifically, Pfizer Animal Health will acquire from
Schering-Plough a number of animal health products for sale in the
European Economic Area covering the following categories:

-- Swine E. coli Vaccines

-- Equine Influenza and Tetanus Vaccines

-- Ruminant Neonatal and Clostridia Vaccines

-- Rabies Vaccines

-- Companion Animal Veterinary Specialty Products

-- Parasiticides & Anti-inflammatories

The acquisition is subject to certain closing conditions,
including antitrust approval. Terms of the agreement were not
disclosed.

Pfizer Animal Health's Europe President, Albert Bourla, said that
the acquisition will enable Pfizer Animal Health Europe to build upon
its comprehensive animal health solutions for veterinarians and their
clients - farmers and pet owners - in Europe. Bourla added, "We look
forward to offering veterinarians additional preventative therapies
and treatments along with our technical expertise and services to
ensure that animals receive the best care possible."


Bullboard Posts